Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹1,913 Cr₹128,186 Cr₹1,433 Cr₹127 Cr₹10,304 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,913 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹1,913 Cr
Mar2024₹128,186 Cr
Mar2023₹1,433 Cr
Mar2022₹127 Cr
Mar2021₹10,304 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹1,913 Cr
-98.51
Mar2024 ₹128,186 Cr
8,842.31
Mar2023 ₹1,433 Cr
1,032.80
Mar2022 ₹127 Cr
-98.77
Mar2021 ₹10,304 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹89,742.7 Cr 1.5% -2.8% -19.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,708.0 Cr -2.9% -1.8% -2.5% Stock Analytics
DIVIS LABORATORIES ₹171,975.0 Cr 2.1% 0.2% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,619.0 Cr 0.5% 2.2% 11.2% Stock Analytics
CIPLA ₹122,539.0 Cr 0.7% -0.8% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,741.0 Cr -0.1% 2.5% 2.5% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-2.8%

-19.5%

SENSEX

-0.4%

-0.3%

3.9%


You may also like the below Video Courses